Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
BMJ Open|December 30, 2022
Cohort Profile:The Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 vaccines (ENFORCE)Nina Breinholt Stærke, Joanne Reekie, Isik S Johansen, et al.
Nature Communications|October 30, 2022
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunityMiriam Rosás-Umbert, Jesper D Gunst, Marie H Pahus, et al.
Clinical and Experimental Rheumatology|October 25, 2023
Revaccination of patients with systemic lupus erythematosus or rheumatoid arthritis without an initial COVID-19 vaccine response elicits seroconversion in half of the patientsChristian Ammitzbøll, Marianne Kragh Thomsen, Jakob Bøgh Andersen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus InfectionLine Vibholm, Mariane H Schleimann, Jesper F Højen, et al.
The Journal of Infectious Diseases|April 30, 2024
Longitudinal Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 T-Cell Immunity Over 2 Years Following Vaccination and InfectionAnna Karina Juhl, Lisa Loksø Dietz, Ole Schmeltz Søgaard, et al.
The Lancet. Microbe|May 11, 2022
Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trialHenning Gruell, Jesper D Gunst, Yehuda Z Cohen, et al.
Nature Communications|August 1, 2022
Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infectionsNina Breinholt Stærke, Joanne Reekie, Henrik Nielsen, et al.
Cell Reports|December 16, 2020
HIV Antibody Fc N-Linked Glycosylation Is Associated with Viral ReboundRasmus Offersen, Wen-Han Yu, Eileen P Scully, et al.
Open Forum Infectious Diseases|June 23, 2023
Association of Self-reported Systemic Reactions Following SARS-CoV-2 Vaccination With Immunological Response in the Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 Vaccines (ENFORCE)Wendy P Bannister, Dorthe Raben, Palle Valentiner-Branth, et al.
Ebiomedicine|March 24, 2022
Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcomeBruna Oriol-Tordera, Anna Esteve-Codina, María Berdasco, et al.
Pageof 14